Trial
NCT00372528
An Open-Label Study Of Pregabalin In Subjects With Refractory Partial Seizures
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Collaborators
—
Condition
Epilepsy
Intervention
pregabalin (LYRICA)
Why stopped
This study was terminated on April 8, 2011 as Pfizer Canada could no longer supply study drug. No efficacy or safety concerns factored into this decision.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-01-26